1. Differences in EEG patterns between tonic and high frequency spinal cord stimulation in chronic pain patients.
- Author
-
Telkes L, Hancu M, Paniccioli S, Grey R, Briotte M, McCarthy K, Raviv N, and Pilitsis JG
- Subjects
- Adult, Aged, Chronic Pain physiopathology, Electroencephalography, Female, Humans, Male, Middle Aged, Pain Management, Treatment Outcome, Alpha Rhythm physiology, Chronic Pain therapy, Frontal Lobe physiopathology, Somatosensory Cortex physiopathology, Spinal Cord Stimulation methods, Theta Rhythm physiology
- Abstract
Objective: To investigate the differences in neural patterns between spinal cord stimulation (SCS) waveforms (60-Hz tonic vs 10-KHz high frequency stimulation, HFS) and their correlation to stimulation-induced pain relief., Methods: We recorded 10-channel electroencephalogram (EEG) in response to stimulation ON and OFF in 9 chronic pain patients (4 women, 5 men) during SCS surgery and examined the intraoperative spatio-spectral EEG features., Results: We discovered stronger relative alpha power in the somatosensory region and higher trend in alpha/theta peak power ratio in frontal cortex with HFS. We also observed a shift in peak frequency from theta to alpha rhythms in HFS as compared to baseline and tonic stimulation, where slower theta activity was maintained. Further, a positive correlation was found between changes in Oswestry disability index (ODI) scores (from preoperative to postoperative) and HFS-induced alpha/theta peak power ratio in frontal and somatosensory regions., Conclusions: Altogether, our findings suggest that dynamic spectral interactions in theta-alpha band and their spatial distributions might be the first intraoperative neural signatures of pain relief induced by HFS in chronic pain., Significance: Examining electrophysiological changes intraoperatively has a potential to elucidate response to SCS therapy prior to device selection, reducing the healthcare expenditures associated with failed implants., Competing Interests: Declaration of Competing Interest Dr. Pilitsis is a consultant for Boston Scientific, Nevro, TerSera and Abbott and receives grant support from Medtronic, Boston Scientific, Abbott, Nevro, TerSera, NIH 2R01CA166379-06, and NIH U44NS115111. She is the medical advisor for Aim Medical Robotics and Karuna and has stock equity. Steven Paniccioli, Rachael Grey, Michael Briotte, and Kevin McCarthy are employees of Nuvasive., (Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF